Because the tumor microenvironment influences the TIL response, it will be important to further characterize the TILs for both antitumor and suppressive phenotypes and quantitate the ratios of activated CTLs (CD8+ICOS++) versus TRegs (CD4+FOXP3+) posttreatment. The gene discussed is CD4; the disease is neoplasm.